A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment
Clinical trial NCT05200286 · COMPLETED
Trial details
- NCT number
- NCT05200286
- Sponsor
- F2G Biotech GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2022-12-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.